2023 annual financial data
Akebia Therapeutics 2023 Net margin
Direct answer
Net margin was -26.68%.
Operating income was -46,256,000 USD and net income was -51,925,000 USD.
Operating cash flow was -23,384,000 USD.
Get free Akebia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 194,623,000 USD
- Operating income
- -46,256,000 USD
- Net income
- -51,925,000 USD
- Operating cash flow
- -23,384,000 USD